Genesis Lifestyle Medicine review

Genesis Lifestyle Medicine currently lists thirteen clinics across six states, where sermorelin and NAD⁺ can be discussed in person. Its separate telehealth arm publishes $129 monthly headlines for sermorelin injection and NAD⁺, with lower monthly equivalents on longer options and a 30-day supply shipped every 30 days. The sermorelin troche headline conflicts with its option range. The group names Alex Spinoso as cofounder, CEO and Chief Medical Officer; the clinic and mailed programs still need separate pricing and pharmacy questions.

Genesis Lifestyle Medicine lists thirteen clinics: four in Tennessee, four in Texas, two in Nevada, and one each in Utah, Indiana and Colorado. Its clinic menu includes weight care, hormone therapy, sermorelin injections or capsules, NAD⁺ injections, patches and nasal sprays, and aesthetics. The separate telehealth storefront sells mailed sermorelin injection and troches, NAD⁺ injection and spray, and other wellness products. Clinic treatment prices are individually quoted; telehealth product pages show plan options. A linked lab store is a separate purchase channel, with current pricing unconfirmed.

The clinics offer in-person evaluation and treatment; the telehealth arm uses a questionnaire, independent physician networks including Beluga Health and shipped prescriptions after approval. The telehealth site names Rush Pharmacy and Artisan Drug as partners, without assigning either to a selected patient. The business names Alex Spinoso as cofounder, CEO and Chief Medical Officer; that role is attributed to its pages, not an independent licensing conclusion. Clinic NAD⁺ and sermorelin offerings should not be assumed identical to mailed formulations. Telehealth advertises biomarker testing, but the separate lab-store price and terms are not currently confirmed. Its return policy treats dispensed prescriptions as final and directs pre-shipping cancellation through the account.

The clinics publish no standard peptide price and quote treatment individually. The telehealth arm advertises sermorelin injection and NAD⁺ injection or spray at $129 a month, with options showing $119 monthly equivalent over three months, $110 over six and $99 over twelve. Product pages say a 30-day supply ships every 30 days, but longer-option initial debit and dose pricing remain unclear. The sermorelin troche headline says $199 while its options show a $99 to $129 range. Ask for the actual selected-plan charge and supply. The separate lab store was not available for a current pricing check, so previously indexed exact test prices should not guide a purchase.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The telehealth arm says so on its product pages — medication is compounded and dispensed by a licensed third-party pharmacy — and names its two pharmacy partners, Rush Pharmacy in Oviedo, Florida, and Artisan Drug in Plano, Texas, with contact details. The clinic site does not state whether its in-office sermorelin is compounded, and no compounded-medication disclaimer appears prominently there, which matters in a practice offering both brand-name Wegovy and Zepbound and compounded semaglutide and tirzepatide. Compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. On the evidence, sermorelin acts on the growth-hormone axis, a real and well-described mechanism, but the long-term human outcome data stays thin and no controlled trial supports the body-composition or anti-aging results the category is marketed on; the capsule and troche routes have no comparative bioavailability data published on the site. Injected, intranasal and patch NAD⁺ have no controlled human outcome trials; oral NR and NMN are the studied forms and they raise a blood level. If you also take up the testosterone line, note that testosterone therapy carries real monitoring requirements and suppresses fertility. Individual results vary.